P-258 5-Year survival of gastric cancer patients after radical surgery was significantly depended on tumor characteristics, blood cell circuit, cell ratio factors, hemostasis system and adjuvant treatment

Annals of Oncology ◽

10.1093/annonc/mdw199.249 ◽

2016 ◽

Vol 27 ◽

pp. ii75

Author(s):

O. Kshivets

Keyword(s):

Gastric Cancer ◽

Blood Cell ◽

Cancer Patients ◽

Adjuvant Treatment ◽

Radical Surgery ◽

Tumor Characteristics ◽

Cell Ratio ◽

Hemostasis System ◽

Cell Circuit ◽

Gastric Cancer Patients

Download Full-text

P1.08-003 Survival of Lung Cancer Patients was Depended on Tumor Characteristics, Blood Cell Circuit, Cell Ratio Factors, Hemostasis System

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2016.11.970 ◽

2017 ◽

Vol 12 (1) ◽

pp. S732

Author(s):

Oleg Kshivets

Keyword(s):

Lung Cancer ◽

Blood Cell ◽

Cancer Patients ◽

Tumor Characteristics ◽

Cell Ratio ◽

Lung Cancer Patients ◽

Hemostasis System ◽

Cell Circuit

Download Full-text

Platelet-to-lymphocyte ratio and lymphocyte-to-white blood cell ratio predict the efficacy of neoadjuvant chemotherapy and the prognosis of locally advanced gastric cancer patients treated with the oxaliplatin and capecitabine regimen

OncoTargets and Therapy ◽

10.2147/ott.s176768 ◽

2018 ◽

Vol Volume 11 ◽

pp. 7061-7075 ◽

Cited By ~ 5

Author(s):

Cheng Tang ◽

Xi Cheng ◽

Shan Yu ◽

Yan Wang ◽

Jun Hou ◽

...

Keyword(s):

Gastric Cancer ◽

Neoadjuvant Chemotherapy ◽

Blood Cell ◽

Advanced Gastric Cancer ◽

Cancer Patients ◽

Locally Advanced ◽

Platelet To Lymphocyte Ratio ◽

Cell Ratio ◽

Locally Advanced Gastric Cancer ◽

Gastric Cancer Patients

Download Full-text

Esophageal cancer patients’ survival after surgery significantly depended on cell ratio factors, blood cell circuit, biochemical factors, hemostasis system, adjuvant chemoimmunoradiotherapy, cancer characteristics, localization, anthropometric data

Annals of Oncology ◽

10.1093/annonc/mdx261.004 ◽

2017 ◽

Vol 28 ◽

pp. iii15

Author(s):

Oleg Kshivets

Keyword(s):

Esophageal Cancer ◽

Blood Cell ◽

Cancer Patients ◽

Anthropometric Data ◽

Cell Ratio ◽

Hemostasis System ◽

Cell Circuit

Download Full-text

The effect of red blood cell transfusion on plasma hepcidin and growth differentiation factor 15 in gastric cancer patients: a prospective study

Annals of Translational Medicine ◽

10.21037/atm.2019.08.33 ◽

2019 ◽

Vol 7 (18) ◽

pp. 466-466

Author(s):

Jingfu Liu ◽

Shan Chen ◽

Xianren Ye

Keyword(s):

Gastric Cancer ◽

Blood Cell ◽

Prospective Study ◽

Cancer Patients ◽

Red Blood Cell ◽

Red Blood Cell Transfusion ◽

Growth Differentiation Factor 15 ◽

Differentiation Factor ◽

Gastric Cancer Patients ◽

A Prospective Study

Download Full-text

720 ORAL An intensive weekly chemotherapeutic regimen with 5fluorouracil, leucovorin, cisplatin and epidoxorubicin (PELFw) as adjuvant treatment in high-risk radically resected gastric cancer patients: results of a randomised controlled trial

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)81015-8 ◽

2005 ◽

Vol 3 (2) ◽

pp. 204-205

Keyword(s):

Gastric Cancer ◽

High Risk ◽

Randomised Controlled Trial ◽

Cancer Patients ◽

Adjuvant Treatment ◽

Controlled Trial ◽

Chemotherapeutic Regimen ◽

Gastric Cancer Patients ◽

Randomised Controlled ◽

Resected Gastric Cancer

Download Full-text

A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-012-1956-1 ◽

2012 ◽

Vol 70 (5) ◽

pp. 665-672 ◽

Cited By ~ 4

Author(s):

Yoon Hee Choi ◽

Sang Cheul Oh ◽

Jun Suk Kim ◽

Seung-Hyun Nam ◽

Bong-Seog Kim ◽

...

Keyword(s):

Gastric Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Adjuvant Treatment ◽

Phase Ii Study ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group ◽

Recurrent Gastric Cancer ◽

Gastric Cancer Patients

Download Full-text

Comparison of two different adjuvant treatment modalities for pN3 gastric cancer patients after D2 lymph node dissection: can we avoid radiotherapy in a subgroup of patients?

Medical Oncology ◽

10.1007/s12032-013-0660-2 ◽

2013 ◽

Vol 30 (3) ◽

Cited By ~ 7

Author(s):

Leyla Kilic ◽

Cetin Ordu ◽

Meltem Ekenel ◽

Ibrahim Yildiz ◽

Serkan Keskin ◽

...

Keyword(s):

Gastric Cancer ◽

Lymph Node ◽

Cancer Patients ◽

Lymph Node Dissection ◽

Adjuvant Treatment ◽

Treatment Modalities ◽

Node Dissection ◽

D2 Lymph Node Dissection ◽

Gastric Cancer Patients

Download Full-text

Adjuvant treatment in stage III gastric cancer patients in Brazil and Peru: Results of a retrospective study in two cancer centers in Latin America.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e16101 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e16101-e16101

Author(s):

Jose Eduardo Nunez ◽

Tiago Felismino ◽

Daniel Enriquez ◽

Paola Catherine Montenegro ◽

Felipe Coimbra ◽

...

Keyword(s):

Gastric Cancer ◽

Latin America ◽

Retrospective Study ◽

Cancer Patients ◽

Adjuvant Treatment ◽

Stage Iii ◽

Cancer Centers ◽

Gastric Cancer Patients

Download Full-text

6547 A phase II study of Docetaxel and Oxaliplatin combination as first-line chemotherapy in recurrent gastric cancer patients after Fluoropyrimidine and/or Cisplatin adjuvant treatment

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71269-8 ◽

2009 ◽

Vol 7 (2) ◽

pp. 375

Author(s):

H. Kang ◽

S. Oh ◽

J. Kim ◽

S. Nam ◽

B. Kim ◽

...

Keyword(s):

Gastric Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Adjuvant Treatment ◽

Phase Ii Study ◽

First Line ◽

Recurrent Gastric Cancer ◽

Gastric Cancer Patients ◽

Line Chemotherapy

Download Full-text

Re: Adjuvant Treatment of High-Risk, Radically Resected Gastric Cancer Patients with 5-Fluorouracil, Leucovorin, Cisplatin, and Epidoxorubicin in a Randomized Controlled Trial

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/djm092 ◽

2007 ◽

Vol 99 (17) ◽

pp. 1345-1346 ◽

Cited By ~ 3

Author(s):

N. Fazio ◽

R. Biffi ◽

G. Curigliano ◽

K. Lorizzo ◽

M. G. Zampino ◽

...

Keyword(s):

Gastric Cancer ◽

Randomized Controlled Trial ◽

High Risk ◽

Cancer Patients ◽

Adjuvant Treatment ◽

Controlled Trial ◽

Randomized Controlled ◽

Gastric Cancer Patients ◽

Resected Gastric Cancer

Download Full-text